IL13 PROMOTER (-1055) POLYMORPHISMS ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN TAIWANESE

REFERENCES

• Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994;265:2037–2048.
   PubMed Web of Science ®Google Scholar
• Joos L, Pare PD, Sandford AJ: Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly. 2002; 132: 27–37.
   PubMed Web of Science ®Google Scholar
• Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, .: Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med. 1995;333:894–900.
   PubMed Web of Science ®Google Scholar
• Doull IJ, Lawrence S, Watson M, Begishvili T, Beasley RW, .: Allelic association of gene markers on chromosome 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 1996;153:1280–1284.
   PubMed Web of Science ®Google Scholar
• A genome-wide search for asthma susceptibility loci in ethnically diverse populations: The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet. 1997;15:389–392.
   PubMed Web of Science ®Google Scholar
• Whittaker L, Niu N, Temann UA, Stoddard A, Flavell RA, .: Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol. 2002;27:593–602.
   PubMed Web of Science ®Google Scholar
• Miotto D, Ruggieri MP, Boschetto P, Cavallesco G, Papi A, .: Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J. 2003;22:602–608.
   PubMed Web of Science ®Google Scholar
• Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, .: Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest. 2000;106:1081–1093.
   PubMed Web of Science ®Google Scholar
• Boutten A, Bonay M, Laribe S, Leseche G, Castier Y, .: Decreased expression of interleukin 13 in human lung emphysema. Thorax. 2004;59:850–854.
   PubMed Web of Science ®Google Scholar
• Van Der Pouw Kraan TC, Kucukaycan M, Bakker AM, Baggen JM, Van Der Zee JS, .: Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun. 2002;3:436–439.
   PubMed Web of Science ®Google Scholar
• Meyers DA, Larj MJ, Lange L. Genetics of asthma and COPD. Similar results for different phenotypes. Chest 2004;126(Suppl):105S–110S, 159S–161S.
   PubMedGoogle Scholar
• Ohar JA, Bleecker ER, Howard TD. IL-13 polymorphism: predisposition towards COPD and asbestos-induced diseases [abstract]. Eur Respir J. 2001;18:P3588.
   Google Scholar
• Hegab AE, Sakamoto T, Saitoh W, Massoud HH, Massoud HM, .: Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest. 2004;126:1832–1839.
   PubMed Web of Science ®Google Scholar
• Sadeghnejad A, Meyers DA, Bottai M, .: L13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function. Am J Respir Crit Care Med. 2007;176:748–752.
   PubMed Web of Science ®Google Scholar
• Cameron L, Webster RB, Strempel JM, .: Th2 cell-selective enhancement of human IL13 transcription by IL13–1112C.T, a polymorphism associated with allergic inflammation. J Immunol. 2006;177:8633–8642.
   PubMed Web of Science ®Google Scholar
• Van Der Pouw Kraan TC, van Veen A, Boeije LC, .: An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 1999;1:61–65.
   PubMed Web of Science ®Google Scholar
• Lee JS, Rosengart MR, Kondragunta V, .: Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res. 2007;8:64.
   PubMedGoogle Scholar
• Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425–456.
   PubMed Web of Science ®Google Scholar
• Ke B, Shen XD, Zhai Y, Gao F, Busuttil RW, .: Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther. 2002;13:1845–1857.
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder RM, Cool CD, .: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163:737–744.
   PubMed Web of Science ®Google Scholar
• Segura-Valdez L, Pardo A, Gaxiola M, .: Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000;17:684–694.
   Google Scholar
• Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269–280.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1997;153:1530–1535.
   Web of Science ®Google Scholar
• Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J. 1995;8:1333–1338.
   PubMed Web of Science ®Google Scholar
• Cohn L, Homer RJ, MacLeod H, .: Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol. 1999;162:6178–6183.
   PubMed Web of Science ®Google Scholar
• McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol. 1998;8:339–342.
   PubMed Web of Science ®Google Scholar